rosiglitazone has been researched along with Hyperoxia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, C; Rehan, VK; Sakurai, R; Shen, H; Walther, FJ; Waring, AJ | 1 |
| Gong, M; Husain, M; Husain, S; Ibe, B; Li, Y; Morales, E; Paek, D; Rehan, VK; Sakurai, R; Torday, JS | 1 |
| Deprest, J; Jimenez, J; Nagatomo, T; Richter, J; Toelen, J; Vanoirbeek, J | 1 |
| Ambalavanan, N; Dasgupta, C; Guo, P; Rehan, VK; Sakurai, R; Torday, JS; Wang, Y | 1 |
| Armstrong, M; de Langhe, S; Dill, E; Gelfand, EW; Irwin, D; Klemm, D; Koster, M; Majka, SM; Nozik-Grayck, E; Okamoto, M; Reisdorf, N; Stenmark, KR; Takeda, K; West, J; Wilder, J | 1 |
| Corral, J; Ibe, B; Ihida-Stansbury, K; Krebs, M; Rehan, VK; Sakurai, R; Torday, JS | 1 |
| Cai, Q; Xu, MY | 1 |
| Patel, S; Rehan, VK; Santos, J; Torday, JS; Wang, Y | 1 |
8 other study(ies) available for rosiglitazone and Hyperoxia
| Article | Year |
|---|---|
A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Biomimetic Materials; Cell Differentiation; Female; Hyperoxia; Lung; Lung Injury; Male; Pioglitazone; PPAR gamma; Protein Precursors; Proteolipids; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Surface-Active Agents | 2018 |
Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Bronchoalveolar Lavage; Cell Differentiation; Female; Hyperoxia; Lung; Lung Injury; Male; Nebulizers and Vaporizers; Pioglitazone; PPAR gamma; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Surface-Active Agents; Thiazolidinediones | 2014 |
Transplacental Administration of Rosiglitazone Attenuates Hyperoxic Lung Injury in a Preterm Rabbit Model.
Topics: Animals; Female; Hyperoxia; Lung Injury; Maternal-Fetal Exchange; Pregnancy; Premature Birth; Rabbits; Rosiglitazone; Thiazolidinediones | 2016 |
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone.
Topics: Actins; Acute Lung Injury; Age Factors; Animals; Animals, Newborn; beta Catenin; Calcium-Binding Proteins; Calponins; Cells, Cultured; Fibroblasts; Hyperoxia; Hypoglycemic Agents; Lac Operon; Lymphoid Enhancer-Binding Factor 1; Mice; Mice, Transgenic; Microfilament Proteins; PPAR gamma; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta; Wnt Proteins | 2009 |
Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.
Topics: Animals; Animals, Newborn; Bronchoconstriction; Cell Differentiation; Disease Models, Animal; Fibroblasts; Humans; Hyperoxia; Infant, Newborn; Infant, Newborn, Diseases; Lung; Lung Diseases; Mice; Mice, Inbred C57BL; Muscle, Smooth; Neovascularization, Physiologic; PPAR gamma; Respiratory System; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2009 |
Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.
Topics: Animals; Animals, Newborn; Cells, Cultured; Female; Fibroblasts; Humans; Hyperoxia; Lung Injury; PPAR gamma; Pregnancy; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2010 |
[Protective effect of rosiglitazone against hyperoxia-induced lung injury in neonatal rats].
Topics: Animals; Animals, Newborn; Bronchoalveolar Lavage Fluid; Female; Hyperoxia; Lung Injury; Male; Malondialdehyde; PPAR gamma; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2012 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo.
Topics: Actins; Anilides; Animals; Animals, Newborn; Cell Differentiation; Cells, Cultured; Female; Fibroblasts; Gene Expression; Hyperoxia; Lung; Lung Diseases; Lung Injury; Male; Membrane Proteins; Perilipin-2; PPAR gamma; Pregnancy; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein B; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2006 |